AORT (STOCKS)
Artivion, Inc.
$28.410000
-0.230000 (-0.80%)
Prev close: $28.640000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- James Patrick Mackin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,445.18M
- Employees
- 1,600
- P/E (TTM)
- -424.30
- P/B (TTM)
- 3.13
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.28 | $0.01 | -0.2902 | -2,845.10% |
|
Mar 2026 (Q1)
|
$0.03 | $0.05 | -0.0201 | -40.12% |
|
Dec 2025 (Q4)
|
$0.05 | $0.08 | -0.0333 | -39.98% |
|
Sep 2025 (Q3)
|
$0.06 | $0.02 | +0.0425 | +242.86% |
Financial Statements
| Revenues | $471.47M |
| Benefits Costs and Expenses | $469.24M |
| Cost Of Revenue | $167.97M |
| Costs And Expenses | $469.24M |
| Gross Profit | $303.50M |
| Operating Expenses | $289.86M |
| Selling, General, and Administrative Expenses | $254.77M |
| Research and Development | $35.10M |
| Operating Income/Loss | $20.64M |
| Income/Loss From Continuing Operations After Tax | -$3.17M |
| Income/Loss From Continuing Operations Before Tax | $2.23M |
| Income Tax Expense/Benefit | $5.40M |
| Net Income/Loss | -$3.17M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$3.17M |
| Net Income/Loss Available To Common Stockholders, Basic | -$3.16M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$12.00K |
| Preferred Stock Dividends And Other Adjustments | -$6.00K |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic | -$6.00K |
| Basic Earnings Per Share | -$0.05 |
| Diluted Earnings Per Share | -$0.07 |
| Basic Average Shares | 144,578,000 |
| Diluted Average Shares | 148,216,000 |
| Assets | $1.07B |
| Current Assets | $371.38M |
| Inventory | $103.36M |
| Other Current Assets | $268.02M |
| Noncurrent Assets | $700.55M |
| Fixed Assets | $73.70M |
| Other Non-current Assets | $626.86M |
| Liabilities | $626.35M |
| Current Liabilities | $106.93M |
| Accounts Payable | $20.87M |
| Wages | $17.84M |
| Other Current Liabilities | $68.22M |
| Noncurrent Liabilities | $519.42M |
| Long-term Debt | $363.42M |
| Other Non-current Liabilities | $156.00M |
| Equity | $445.59M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $445.59M |
| Liabilities And Equity | $1.07B |
| Net Cash Flow From Operating Activities | $41.71M |
| Net Cash Flow From Operating Activities, Continuing | $41.71M |
| Net Cash Flow From Investing Activities | -$175.03M |
| Net Cash Flow From Investing Activities, Continuing | -$175.03M |
| Net Cash Flow From Financing Activities | $157.60M |
| Net Cash Flow From Financing Activities, Continuing | $157.60M |
| Exchange Gains/Losses | -$440.00K |
| Net Cash Flow | $23.84M |
| Net Cash Flow, Continuing | $24.28M |
| Comprehensive Income/Loss | -$12.81M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$12.81M |
| Other Comprehensive Income/Loss | -$12.81M |